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Abstract 33 
Purpose. Despite athletes demonstrate a lower cardiovascular risk and superior vascular function 34 
compared to sedentary peers, they are not exempted from cardiac events (i.e., myocardial infarction 35 
[MI]). The presence of a MI is associated with increased cardiovascular risk and impaired vascular 36 
function. We tested the hypothesis that lifelong exercise training in post-MI athletes, similar as in 37 
healthy controls, is associated with a superior peripheral vascular function and structure compared 38 
to a sedentary lifestyle in post-MI individuals. 39 
Methods. We included 18 veteran (>20 years) athletes (ATH) and 18 sedentary controls (SED). To 40 
understand the impact of lifelong exercise training following MI, we included 20 veteran post-MI 41 
athletes (ATH+MI) and 19 sedentary post-MI controls (SED+MI). Participants underwent 42 
comprehensive assessment using vascular ultrasound (vascular stiffness, intima-media thickness 43 
(IMT), and endothelium (in)dependent mediated dilation). Lifetime Risk Score was calculated for a 44 
30-year risk prediction of cardiovascular disease mortality of the participants. 45 
Results. ATH demonstrated a lower vascular stiffness, and smaller femoral IMT compared to SED. 46 
Vascular function and structure did not differ between ATH+MI and SED+MI. ATH (4.0%±5.1) 47 
and ATH+MI (6.1%±3.7) had a significantly better lifetime risk score compared to their sedentary 48 
peers (SED: 6.9%±3.7 and SED+MI: 9.3%±4.8). ATH+MI had no secondary events versus two 49 
recurrent MI and six elective percutaneous coronary interventions within SED+MI (P<0.05). 50 
Conclusion. Although veteran post-MI athletes did not have a superior peripheral vascular function 51 
and structure compared to their sedentary post-MI peers, benefits of lifelong exercise training in 52 
veteran post-MI athletes relate to a better cardiovascular risk profile and lower occurrence of 53 
secondary events.  54 
 55 
Key Words: physical activity; endothelial function; cardiovascular risk; secondary prevention; 56 
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INTRODUCTION 58 
Exercise training is an effective strategy to lower the risk for cardiovascular diseases (21, 32, 36). 59 
The marked cardio-protective effects of exercise are in part explained via traditional risk factors, 60 
such as a lower cholesterol level, blood pressure, and body mass index (19, 24). Additional benefits 61 
of regular exercise training may relate to a direct effect on the arterial wall, leading to remodeling of 62 
the arteries and improvement of endothelial function (35). For example, exercise training exerts its 63 
benefits on the artery wall through repeated elevation in blood flow and vascular laminar shear 64 
stress, which results in increased nitric oxide bioavailability, promotion of an antioxidant state, and 65 
improvement in vascular function and structure (8, 18).  66 
 67 
Previous studies comparing athletes and sedentary controls consistently found that athletes have 68 
higher vascular compliance and better vascular wall structure compared to sedentary controls (33, 69 
35). Younger athletes also typically demonstrate outward remodelling, as evidenced by larger 70 
conduit artery diameters and a larger resistance artery vascular bed (17). Some controversy is 71 
present around the effects of regular exercise training on endothelial function of conduit arteries 72 
measured with the flow-mediated dilation (FMD) (6, 15, 16, 27, 40). Variation in FMD between 73 
these studies may, at least partly, relate to structural remodelling in athletes (i.e., larger diameter in 74 
athletes), that may contribute to a lower FMD (16). Exercise training is a widely accepted powerful 75 
strategy to lower risk for future cardiovascular events, which is at least partly related to improved 76 
vascular function (12).  77 
 78 
Despite the vascular health benefits and reduction of cardiovascular risk with regular exercise (19, 79 
24, 32, 36), veteran athletes are not exempted from acute coronary syndromes or myocardial 80 
infarction (22, 38). Previous work demonstrated that post-myocardial infarction (post-MI) patients 81 
have an impaired vascular function and structure compared to healthy peers (1, 10). Whether 82 
lifelong exercise training in post-MI patients may be associated with a preserved vascular function 83 
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and structure is currently unknown. Therefore, we tested the hypothesis that lifelong exercise 84 
training in post-MI athletes, similar as in healthy controls, is associated with a superior peripheral 85 
vascular function and structure compared to a sedentary lifestyle in post-MI individuals.  86 
 87 
METHODS 88 
Participants 89 
In total, we included 75 middle-aged men. We included 36 healthy, asymptomatic men who were 90 
divided over two groups: a) 18 veteran (>20 years) athletes (ATH) and b) 18 sedentary controls 91 
(SED). To understand the role of a MI on the impact of lifelong exercise, we included 39 92 
participants who were divided into: a) 20 veteran (>20 years) post-MI athletes (ATH+MI) and b) 19 93 
sedentary post-MI controls (SED+MI). Athletes performed regular moderate or vigorous endurance 94 
exercise training (e.g., running or cycling) for ≥3.5 hours per week for ≥20 years. Sedentary 95 
individuals performed habitual physical activities for ≤2 hours per week for ≥20 years. Smokers, 96 
participants with diabetes mellitus type 1 or 2, and those not able to perform an incremental 97 
maximal cycling test were excluded from participation in our study. The Local Committee on 98 
Research Involving Human Subjects of the region Arnhem and Nijmegen approved the study and 99 
the study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. All 100 
participants gave their written informed consent. 101 
 102 
Lifelong exercise history 103 
We asked the participants about their lifelong exercise history over five age-periods: I) 20-29 years, 104 
II) 30-39 years, III) 40-49 years, IV) 50-59 years, and V) >60 years. Three queries were asked per 105 
period: 1) type of activity (e.g., running, cycling, etc., or nothing), 2) exercise time (hours) per 106 
activity per week, and (3) self-perceived exercise intensity (light, moderate, or vigorous) per 107 
activity. Based on Ainsworth’s compendium of physical activities (2), we determined the 108 
corresponding metabolic equivalent of task (MET) score per activity. Based on the ACSM position 109 
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stand (13), we defined moderate intensity activities between 3 and 5.9 MET, and vigorous intensity 110 
activities as ≥6 MET. Weekly exercise time was defined as the amount of time (in hours) spent on 111 
moderate and/or vigorous intensity exercise activities per week. The average weekly exercise time 112 
and intensity (i.e., percentage of time spent on light, moderate, and vigorous intensity) were 113 
calculated over the last 20 years before study participation. 114 
 115 
Experimental design 116 
Participants visited our laboratory on two separate days during this cross-sectional study. On Day 1, 117 
participants were medically screened for eligibility, followed by an incremental maximal cycling 118 
test. On Day 2, participants underwent a comprehensive assessment of vascular function and 119 
structure using non-invasive echo-Doppler ultrasound techniques. 120 
 121 
Experimental measures 122 
Day 1: Screening + Incremental maximal cycling test 123 
Screening. A physician medically screened participants by taking a detailed medical history, 124 
physical examination, and 12-lead electrocardiogram. Cardiac medical history of the post-MI 125 
participants was retrieved from their medical history reports, which encompassed the clinical 126 
diagnosis of the MI, details of the size and location of the MI, and treatment strategy. To gain 127 
insight in the cardiovascular risk profile of the participants, we calculated the Lifetime Risk Score 128 
(LRS) for a 30-year risk prediction of cardiovascular disease mortality (4). Parameters taken into 129 
account for the LRS were age, systolic blood pressure, total cholesterol, physical fitness level, and 130 
body mass index. 131 
 132 
Incremental maximal cycling test. Peak oxygen uptake (VO2peak, mLO2/min/kg) of the participants 133 
was determined via an incremental maximal cycling test. Heart rate was continuously measured via 134 
a 12 lead-electrocardiogram. Oxygen uptake (VO2 [ml/min]), carbon dioxide output (VCO2 135 
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[ml/min]), and respiratory exchange ratio (RER) were measured via a gas analyser (CPET, Cosmed 136 
v9.1b, Rome, Italy). Lactate concentration (mmol/L) was measured via a capillary blood sample 137 
taken one-and-a-half minute after cessation of the test with the Lactate Pro™ 2 (Arkray, type LT-138 
1730, Kyoto, Japan). 139 
 140 
Day 2: Vascular function and structure 141 
All measurements were performed according to recent guidelines for vascular assessment and in a 142 
temperature-controlled room (34) using a T3000 ultrasound system (Terason Teratech Corporation, 143 
Boston, United States) equipped with a 10-MHz 12L5 linear transducer. Continuous Doppler 144 
velocity was obtained using a position insonification angle of <60° (6). Participants followed a ≥6h 145 
fasting period, ≥18h abstinence from caffeine, alcohol, vitamin supplements, and performed no 146 
vigorous physical activity at least 24h before the test. Measurements began after a resting period in 147 
the supine position for at least 15 minutes (34). Subsequently, heart rate and blood pressure were 148 
manually assessed using a sphygmomanometer. Blood samples were obtained after the vascular 149 
measurements from the antecubital vein for the analysis of blood glucose, and traditional 150 
cardiovascular risk markers (cholesterol, HDL, LDL, triglycerides, and glycated hemoglobin 151 
[HbA1c]).  152 
 153 
Brachial artery endothelium-dependent flow-mediated dilatation (FMD). The FMD (an index of 154 
endothelial function) of the brachial artery was measured by positioning the Echo-Doppler probe on 155 
the brachial artery. A pneumatic cuff (E20 rapid cuff inflator, Hokanson, Bellevue, United States) 156 
was placed on the right forearm, distally from the imaged artery. Diameter and flow velocity were 157 
recorded at the baseline during one-minute, followed by 5 minutes of ischemia by inflating the 158 
pneumatic cuff at 220 mmHg. Diameter and blood velocity recordings resumed 30 seconds before 159 
deflating the cuff and continued for 3 minutes thereafter, during the reperfusion (34).  160 
 161 
7 
 
Brachial artery conduit artery vasodilatory capacity (CADC). After a 20-minute resting period, the 162 
CADC (an index of arterial structure) was measured using the same equipment. The pneumatic cuff 163 
was inflated to 220 mmHg on the right upper arm, proximal from the imaged artery, for 5 minutes. 164 
Participants performed handgrip exercise from minute one until minute four (one-second 165 
contraction/one-second relaxation) at ~30 newton during the ischemic period. Diameter and blood 166 
velocity recordings resumed 30 seconds before deflating the cuff and continued for 3 minutes 167 
thereafter, to detect peak flow and peak diameter (26).  168 
 169 
Brachial artery endothelium-independent dilatation. After another 20-minute rest, the vasodilator 170 
response to glyceryl trinitrate mediated vasodilatation (GTN; an index of vascular smooth muscle 171 
function) was measured. After recording baseline brachial artery diameter across 1-min, a single 172 
dose (400 µg) sublingual GTN (nitric oxide donor) was administered. Recording of diameter and 173 
blood velocity of the artery continuous 8 minute thereafter (14).  174 
 175 
FMD, CADC, and GTN dilation were analyzed by custom-designed edge-detection and wall 176 
tracking software written in LabVIEW (LabVIEW 6.02, National Instruments, Austin, United 177 
States) as described elsewhere (5). Briefly, from B-mode a region of interest (ROI) was drawn to 178 
calibrate the artery diameter. Within this ROI a pixel-density algorithm automatically identified the 179 
vessel wall. For the calibration of the blood flow velocity another ROI was drawn around the 180 
Doppler waveform. Baseline diameter was calculated as the mean of data acquired during one-181 
minute baseline recording, preceding cuff inflation. Peak diameter and peak of blood flow velocity 182 
was detected during three minutes of reperfusion. Brachial artery FMD, CADC, and GTN response 183 
were calculated as the relative difference in peak diameter and baseline diameter.  184 
 185 
 186 
 187 
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Pulse wave velocity: vascular stiffness  188 
As an index for vascular stiffness, central and peripheral pulse wave velocity were measured using a 189 
three-lead electrocardiogram and an Echo-Doppler ultrasound machine (Waki Doppler, Atys 190 
Medical, Soucieu en Jarrest, France) at the left carotid artery, right common femoral artery, and 191 
radial artery. The distances were measured between sternal notch and site of measurement for the 192 
carotid artery and between radial artery and common femoral artery via the umbilicus (20). At least 193 
10 cardiac cycles were recorded for analyses. Based on the interval between the R-wave on the 194 
electrocardiogram and onset of the Doppler waveform, central and peripheral pulse wave velocities 195 
were calculated in Matlab (MATLAB and Statistics Toolbox Release R2014, The MathWorks, Inc., 196 
Natick, United States). 197 
 198 
Conduit artery intima-media thickness 199 
Intima-media thickness (IMT) of the left common carotid, brachial, and superficial femoral artery 200 
were recorded using the same ultrasound machine. Image sequences of ≥10 seconds were recorded 201 
1.5 to 2.5 cm distally of the bifurcation of the common carotid and superficial artery, while having 202 
the vessel in a longitudinal imaging plane. Diameter and wall thickness were collected from two 203 
distinct angles. Analysis was performed using custom-designed off-line edge-detection and wall-204 
tracking software written in LabVIEW (LabVIEW 6.02, National Instruments, Austin, United 205 
States). This DICOM-based software is largely independent of investigator bias and has been 206 
previously described in detail (28, 29). Briefly, each recording was converted to a DICOM file at a 207 
frame rate of 30 Hz. Detection of the far wall media-adventitia interface was performed on every 208 
frame selected. The mean diameter and wall thickness were calculated by using the formula: (1/3 x 209 
systolic diameter or wall thickness) + (2/3 x diastolic diameter or wall thickness). Additionally, to 210 
correct for differences in vascular tone between measurements wall:lumen-ratio was calculated. All 211 
files were analyzed blinded by an independent researcher. 212 
 213 
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Power calculation and statistical analysis 214 
Based on anticipated difference in %FMD between study groups of 3.5% with a SD of 2.4 (6, 10), a 215 
power of 90% and alpha 5% significance level, we calculated that 18 subjects per group should be 216 
included.  To correct for possible drop-out, we included 20 subjects per study group.  217 
 218 
Characteristics of the participants and vascular function and vascular structure were summarized 219 
with means and standard deviations or median and interquartile range (IQR), when appropriate. 220 
Categorical data were analysed using the Fisher's exact test. Parameters were checked for normality 221 
using a Shapiro-Wilk test. Non-normal data were Ln-transformed before the statistical analysis. 222 
Data that could not be transformed into Gaussian distribution were analysed using nonparametric 223 
tests. For aim 1 and 2, differences between veteran athletes and sedentary peers, either with or 224 
without a history of MI, were assessed using an independent Student's t or Mann-Whitney U test, 225 
when appropriate. All statistical analyses were performed using SPSS 21.0 software (IBM Corp. 226 
Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.). 227 
Statistical significance was assumed at p<0.05 (two-sided). 228 
 229 
RESULTS 230 
Veteran athletes vs. sedentary controls 231 
ATH had a lower body weight and body mass index compared to SED, whilst no differences were 232 
present for age, height, and mean arterial pressure (Table 1). ATH performed significantly more 233 
exercise per week compared to SED (7.1 hours/weeks [5.8-11.9] vs. 0.5 hours/weeks [0.0-1.4], 234 
P<0.01), respectively. ATH performed most of their activities at a moderate intensity (66%), 235 
followed by vigorous (33%) and light intensity (1%). ATH reached a higher VO2peak and power 236 
output during the incremental exercise test compared to SED (Table 1). ATH showed higher HDL 237 
and lower LDL and triglyceride levels compared to SED, whilst no differences were found for 238 
HbA1c and cholesterol (Table 1). As a consequence of these differences, ATH demonstrated a 239 
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lower lifetime risk score compared to SED (Table 1). Participants with a positive family history of 240 
cardiovascular diseases did not differ between ATH (n=8, 44%) and SED (n=6, 33%), P=0.73. 241 
 242 
Vascular function + structure. Whilst ATH and SED did not differ in brachial diameter and SRAUC, 243 
the FMD was lower in ATH compared to SED (Table 2). We found no differences between ATH 244 
and SED for CADC or GTN response, whereas FMD/GTN ratio was significantly lower in ATH 245 
compared to SED (Table 2). ATH demonstrated a lower central and peripheral pulse wave velocity 246 
(i.e., higher vascular compliance) compared to SED (Figure 1). No differences between groups 247 
were found for IMT, diameter, and wall:lumen-ratio of the carotid and brachial artery, whilst 248 
femoral artery IMT and wall:-lumen-ratio was smaller in ATH compared to SED (Table 2). 249 
 250 
Veteran post-MI athletes vs. sedentary post-MI controls 251 
ATH+MI had a lower body weight and body mass index compared to SED+MI (Table 3). ATH+MI 252 
performed significantly more exercise per week compared to SED+MI (5.7 hours/week [4.9-9.4] vs. 253 
0.2 hours/week [0.0-1.2], P<0.01), respectively. ATH+MI performed most of their activities at a 254 
moderate intensity (63%), followed by vigorous (34%) and light intensity (3%). Intensity patterns 255 
did not differ between ATH and ATH+MI. ATH+MI reached a higher VO2peak and power output 256 
during the incremental exercise test compared to SED+MI (Table 3). Cholesterol, HDL, and LDL 257 
levels did not differ between ATH+MI and SED+MI, but ATH+MI had lower triglyceride levels 258 
compared to SED+MI (Table 3). ATH+MI demonstrated a lower lifetime risk score compared to 259 
SED+MI (Table 3). Participants with a positive family history of cardiovascular diseases did not 260 
differ between ATH+MI (n=15, 75%) and SED+MI (n=15, 79%), P=1.00. 261 
No differences were observed in extent and location of the MI between groups (Table 4). Treatment 262 
strategy (surgical and rehabilitation) did not differ between groups (Table 4). Six SED+MI needed 263 
an elective percutaneous coronary intervention (PCI) and two reported a recurrent MI, whereas 264 
none of the ATH+MI needed an elective PCI or reported a recurrent MI. The use of anticoagulants, 265 
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lipid lowering and antihypertensive agents did not differ between groups, whilst fewer ATH+MI 266 
used ACE-inhibitors (Table 4).  267 
   268 
Vascular function + structure. We found no significant differences between ATH+MI and SED+MI 269 
for brachial artery diameter, FMD, CADC, GTN, or GTN/FMD ratio (Table 5). We also found no 270 
differences between groups for central or peripheral pulse wave velocity (Figure 1). We found no 271 
significant differences in carotid, brachial and femoral artery IMT, diameter and wall:lumen-ratio 272 
between groups. 273 
 274 
DISCUSSION 275 
We present the following findings. First, in line with our hypothesis, some markers of vascular 276 
function (i.e., pulse wave velocity) and structure (i.e., femoral IMT and wall:lumen-ratio) were 277 
significantly better in asymptomatic veteran athletes compared to their sedentary peers, potentially 278 
contributing to the benefits of lifelong exercise. Second, in contrast with our hypothesis, we found 279 
no differences in vascular function or structure between veteran post-MI athletes and sedentary 280 
post-MI controls, which may be a consequence of pharmaceutical strategies. Third, veteran athletes 281 
with or without a history of MI had a significantly better cardiovascular risk profile compared to 282 
their sedentary peers. Furthermore, veteran post-MI athletes reported no secondary events, which 283 
contrasts the 8 events that occurred in the sedentary post-MI controls. Taken together, our findings 284 
indicate that veteran post-MI athletes do not have a superior vascular function and structure 285 
compared to their sedentary peers, whilst benefits of lifelong exercise relate to better cardiovascular 286 
risk profile and a lower occurrence in secondary events.  287 
 288 
Impact of lifelong exercise on vascular function and structure: asymptomatic individuals 289 
Our results support the hypothesis that benefits of lifelong exercise training go beyond traditional 290 
risk factors (19) and improves functional and structural aspects of the vascular system. For example, 291 
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femoral IMT was significantly smaller in veteran athletes compared to sedentary controls, which is 292 
in line with previous studies that report that regular exercise training is associated with a smaller 293 
conduit artery wall thickness (25, 30). Related to functional characteristics of the vasculature, we 294 
found that veteran athletes have a higher central and peripheral vascular compliance compared to 295 
sedentary controls. This observation confirms previous studies which demonstrated that exercise 296 
training improves arterial compliance (3, 33).  297 
 298 
Somewhat conflicting with the observations related to central and peripheral compliance, we 299 
observed a significantly lower FMD in veteran athletes compared to their sedentary peers. A 300 
previous study demonstrated that young healthy athletes had a lower FMD compared to their 301 
sedentary peers (5.1% vs. 6.0% respectively) (16). The authors suggested that the lower FMD in 302 
young athletes might relate to inherent structural changes in the artery and the interaction between 303 
artery structure and function (16). In the present study, however, baseline diameter did not differ 304 
between athletes and sedentary controls. It is therefore unlikely that structural differences explain 305 
the lower FMD responses among athletes. Also differences in smooth muscle cell sensitivity for 306 
nitric oxide cannot explain our results, since the GTN response did not differ between groups 307 
(ATH: 17.1%±6.7 vs. SED: 15.1±5.4, P=0.33). Alternatively, an interaction between vasodilator 308 
mechanisms and the autonomic sympathetic nervous system may contribute to a lower FMD in 309 
athletes (16). Athletes typically exhibit altered autonomic balance, which may contribute to 310 
attenuated conduit artery endothelium-dependent responses to elevation in shear (16). However, 311 
future studies are necessary to explore this hypothesis. Our findings indicate that endothelial flow-312 
mediated vasodilation is lower in veteran athletes compared to their sedentary peers, whereas 313 
differences are not simply related to structural differences or smooth muscle sensitivity between 314 
groups.  315 
 316 
 317 
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Impact of lifelong exercise on vascular function and structure: post-MI individuals 318 
Although a history of MI is associated with impairment in cardiovascular risk and vascular 319 
function, regular exercise training is known to improve cardiovascular risk and vascular function. 320 
However, in the present study no differences in vascular function and structure were found between 321 
veteran post-MI athletes and sedentary post-MI peers. A possible explanation for these unexpected 322 
observations may relate to the extent of the MI. However, we observed no differences in cardiac 323 
enzyme markers, location of the MI and duration since MI between ATH-MI and SED-MI. 324 
Alternatively, previous studies that revealed an impaired endothelial function in post-MI patients 325 
observed these effects within 1-12 months following MI (1, 10), whereas we measured the 326 
endothelial function after 7±5 years following MI. Since the endothelium recovers during the first 327 
months post-MI (39), our results may be partly explained by the long time since MI and/or bias in 328 
selecting ‘healthy’ post-MI patients given the long time since MI. Finally, prescription of 329 
medication after MI may contribute to our observations, especially since several cardiac 330 
medications directly improve endothelial function (23, 41). Antihypertensive agents most likely 331 
decrease in oxidative stress and increase nitric oxide bioavailability (23), whereas statins are 332 
associated with an improvement in endothelial function and FMD (41). Therefore, the combination 333 
of the prolonged post-MI period and use of cardiac medications may ameliorate endothelial 334 
function and structure in both post-MI groups. This might explain absence of differences in vascular 335 
function and structure between post-MI athletes and sedentary peers. 336 
 337 
Despite the absence of differences in vascular function and marginal differences in cardiovascular 338 
risk factors, veteran post-MI athletes showed a better cardiovascular lifetime risk score compared to 339 
their sedentary post-MI peers. The higher cardiorespiratory fitness in athletes was the major 340 
contributor to the better risk score among athletes. Cardiorespiratory fitness is strongly related with 341 
reduced risk for morbidity and mortality as well it mitigates the risk of a second cardiac event (7, 9). 342 
Although, our study was not powered to investigate the relation between lifelong exercise and 343 
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secondary events following MI, our results indicated that post-MI athletes reported fewer 344 
complications (elective PCI or recurrent MI) after the MI compared to their sedentary post-MI 345 
peers. Alternative benefits of regular exercise training may relate to an improvement in circulating 346 
hormones, endothelial progenitor cells, and/or (exercise) preconditioning of the vasculature (11, 31, 347 
37). Future research is warranted to elucidate benefits of exercise training in more detail to close the 348 
‘risk factor gap’ in cardiovascular disease (19).  349 
 350 
LIMITATIONS 351 
This study was inherent to some limitations. First, the cross-sectional design of our study makes it 352 
difficult to give detailed view of the development of vascular function and structure across time and 353 
study the impact of a MI. Second, post-MI participants were allowed to take their medication before 354 
the measurements due to ethical considerations. Medication usage might influence the results of the 355 
vasculature. However, since both post-MI groups took their medication, we believe it likely that the 356 
medication effect on the vasculature did not influenced our major observations regarding the 357 
comparison between post-MI groups. Finally, most of our veteran athletes performed primarily 358 
lower limb endurance exercises, such as running and cycling. Therefore, it is difficult to translate 359 
our results to other types of exercise training, especially since resistance exercise training may be of 360 
special interest in older populations. 361 
 362 
CONCLUSION 363 
The present study indicates that some markers of vascular function (i.e., compliance) and structure 364 
(i.e., femoral IMT and wall:lumen-ratio) were significantly better in asymptomatic veteran athletes 365 
compared to their sedentary peers. Whilst these observations are in line with previous reports and 366 
emphasise the benefits of regular exercise, we unexpectedly found no differences in vascular 367 
function and structure between veteran post-MI athletes and sedentary post-MI controls. Whilst 368 
medication use may contribute to these findings, regular exercise training in veteran post-MI 369 
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athletes was still associated with significantly better cardiovascular risk profile and lower 370 
occurrence of secondary events compared to sedentary post-MI controls.  371 
 372 
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FIGURES 500 
 
Figure 1. Arterial stiffness of (A) athletes (circles) vs. sedentary controls (squares) and (B) 
athletes+MI (triangles) and sedentary controls+MI (diamonds) of the central pulse wave velocity 
and peripheral pulse wave velocity. Athletes had lower central and peripheral pulse wave velocity, 
indicating that athletes had decreased vascular stiffness (i.e., higher vascular compliance) compared 
to sedentary controls. No differences were observed in vascular stiffness between post-MI groups. 
Data is presented as median and interquartile range. 
cPWV: central pulse wave velocity, pPWV: peripheral pulse wave velocity 
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Table 1. Characteristics of the athletes (ATH) vs. sedentary (SED) controls. Data is 
presented as mean and standard deviation or median and interquartile range. P-value refers 
to an independent Student’s t test or Mann-Whitney U test. 
 ATH 
n=18 
SED 
n=18 
p value 
 
CHARACTERISTICS 
Age (years) 61±7 58±7 0.29 
Height (cm) 179±8 181±6 0.31 
Weight (kg) 74±8 87±10 <0.01 
Body Mass Index (kg/m2) 23.6 (21.1-24.9) 26.7 (25.0-27.4) <0.01 
Mean arterial pressure (mmHg) 98 (90-106) 103 (93-107) 0.70 
 Systolic Blood Pressure (mmHg) 134 (122-142) 136 (124-146) 0.53 
 Diastolic Blood Pressure (mmHg) 84±10 84±10 0.92 
Resting Heart Rate (beats/min) 52±6 64±11 <0.01 
Exercise time (hours/week) 7.1 (5.8-11.9) 0.5 (0.0-1.4) <0.01 
INCREMENTAL EXERCISE TEST 
VO2peak (mL/min/kg) 48.0±8.5 32.8±5.2 <0.01 
Maximal heart rate (beats/min) 165±13 171±15 0.29 
RER (ratio: VCO2 / VO2) 1.13 (1.06-1.17) 1.08 (1.05-1.14) 0.020 
Lactate (mmol/L) 8.9 (11.6-12.3) 11.1 (9.4-12.8) 0.77 
Power Output (W) 319±58 209±46 <0.01 
CARDIOVASCULAR RISK PROFILE 
Lifetime risk score 4.0 (1.7-7.0) 6.9 (4.4-10.2) <0.05 
Glucose (mmol/L) 4.6 (4.4-5.0) 4.7 (4.4-4.9) 0.66 
HbA1c (mmol/mol) 35.5 (34.4-38.3) 35.5 (35.5-38.3) 0.53 
Cholesterol (mmol/L) 5.4±0.8 5.9±0.9 0.07 
HDL (mmol/L) 1.8±0.3 1.4±0.3 <0.01 
LDL (mmol/L) 3.3±0.8 4.0±0.8 <0.05 
Triglycerides (mmol/L) 0.8 (0.7-1.2) 1.3 (1.0-2.4) <0.01 
RER: Respiratory Exchange Ratio; HbA1c: Glycated haemoglobin; HDL: High-density 
lipoprotein; LDL: low-density lipoprotein. 
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Table 2. Vascular function and structure of the athletes (ATH) and sedentary (SED) controls. 
Data is presented as mean and standard deviation or median and interquartile range (IQR). P-
value refers to an independent Student’s t test or Mann-Whitney U test. 
 
ATH 
n=18 
SED 
n=18 
p value 
VASCULAR FUNCTION 
FLOW MEDIATED DILATION 
Baseline diameter (mm) 4.3 (3.9-4.9) 4.4 (4.3-4.5) 0.65 
Peak dilation (%) 3.8±1.7 6.4±2.8 <0.01 
Shear Rate (AUC) 21177 (14041-31869) 18251 (12830-23160) 0.34 
CONDUIT ARTERY VASODILATORY CAPACITY 
Baseline diameter (mm) 4.4±0.6 4.3±0.6 0.84 
Peak dilation (%) 16.0±4.9 15.2±8.9 0.75 
Shear Rate (AUC) 32380±10375 34566±13973 0.61 
GLYCERYL TRINITRATE DILATATION 
Baseline diameter (mm) 4.2±0.6 4.4±0.8 0.43 
Peak dilation (%) 17.1±6.7 15.1±5.4 0.33 
FMD / GTN ratio 0.23 (0.15-0.30) 0.40 (0.25-0.69) <0.01 
VASCULAR STRUCTURE 
CAROTID ARTERY 
IMT (mm) 0.69 (0.58-0.81) 0.71 (0.65-0.86) 0.16 
Diameter (mm) 6.4 (5.8-6.7) 6.8 (6.4-7.3) 0.07 
wall:lumen-ratio 0.11 (0.09-0.13) 0.11 (0.10-0.12) 0.79 
BRACHIAL ARTERY 
IMT (mm) 0.44±0.11 0.47±0.11 0.41 
Diameter (mm) 4.0 (3.8-4.3) 4.4 (3.8-4.8) 0.13 
wall:lumen-ratio 0.11 (0.09-0.13) 0.10 (0.09-0.11) 0.84 
FEMORAL ARTERY 
IMT (mm) 0.59 (0.52-0.65) 0.64 (0.58-0.71) <0.05 
Diameter (mm) 7.3±1.4 6.9±0.7 0.23 
wall:lumen-ratio 0.08 (0.06-0.09) 0.09 (0.08-0.11) 0.01 
AUC: area under the curve; IMT: Intima-media thickness 
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Table 3. Characteristics of the post-MI athletes (ATH+MI) vs. sedentary post-MI (SED+MI) controls. 
Data is presented as mean and standard deviation or median and interquartile range. P-value refers to an 
independent Student’s t test, Mann-Whitney U test, or Fisher's exact test. 
 
ATH+MI 
n=20 
SED+MI 
n=19 
p value 
CHARACTERISTICS 
Age (years) 60±6 61±5 0.44 
Height (cm) 176±5 176±6 0.72 
Weight (kg) 77±7 84±13 <0.05 
Body Mass Index (kg/m2) 24.5 (23.9-26.0) 26.8 (24.3-28.6) <0.05 
Mean arterial pressure (mmHg) 95 (93-100) 92 (88-101) 0.17 
 Systolic Blood Pressure (mmHg) 131 (126-142) 124 (114-136) 0.051 
 Diastolic Blood Pressure (mmHg) 79±9 77±11 0.49 
Resting Heart rate (beats/min) 57±7 60±9 0.26 
Exercise time (hours/week) 5.7 (4.9-9.4) 0.2 (0.0-1.2) <0.01 
Post-MI time before study participation (years) 5 (3-10) 7 (4-10) 0.73 
INCREMENTAL EXERCISE TEST 
VO2peak (mL/min/kg) 40.9±5.5 29.7±6.0 <0.01 
Maximal heart rate (beats/min) 164±15 146±18 <0.01 
RER (ratio: VCO2 / VO2) 1.10 (1.07-1.15) 1.08 (1.05-1.14) 0.31 
Lactate (mmol/L) 10.5 (9.2-11.2) 11.5 (9.4-12.4) 0.19 
Power Output (W) 274±40 190±49 <0.01 
CARDIOVASCULAR RISK PROFILE 
Lifetime risk score 5.4 (3.3-8.6) 8.6 (6.2-12.8) <0.05 
Glucose (mmol/L) 4.6 (4.5-5.0) 4.8 (4.4-5.0) 0.95 
HbA1c (mmol/mol) 36.6 (35.5-37.7) 37.7 (37.4-40.2) <0.01 
Cholesterol (mmol/L) 4.5±0.9 4.2±0.9 0.25 
HDL (mmol/L) 1.6±0.4 1.4±0.3 0.08 
LDL (mmol/L) 2.6±0.8 2.3±0.7 0.22 
Triglycerides (mmol/L) 0.9 (0.8-1.1) 1.2 (1.0-2.0) <0.05 
RER: Respiratory Exchange Ratio; HbA1c: Glycated haemoglobin; HDL: High-density lipoprotein; LDL: 
low-density lipoprotein. 
 507 
  508 
25 
 
Table 4. Cardiac medical history data of post-MI athletes (ATH+MI) vs. sedentary post-MI (SED+MI) controls. P-
value refers to an independent Student’s t, Mann-Whitney U, or Fisher's exact test (two-sided). Data is presented as 
mean and standard deviation or median and interquartile range. 
 
ATH+MI SED+MI p-value 
Post-MI time before study participation (years) 5 (3-10) 7 (4-10) 0.73 
ENZYME MARKERS* 
CK (u/L) n=17 775 (251-2029) n=17 871 (422-2467) 0.45 
CREAT (umol/L) n=14 87 (78-103) n=16 89 (77-93) 0.70 
AST (u/L) n=14 38 (26-135) n=15 84 (36-208) 0.22 
LDH (u/L) n=13 407 (335-638) n=14 422 (178-537) 0.52 
INFARCT LOCATION 
Anterior (n) 7 (35%) 10 (53%) 0.34 
Inferior (n) 7 (35%) 8 (42%) 0.75 
Non-STEMI (n) 6 (30%) 1 (5%) 0.09 
TREATMENT* 
PCI (n [%]) 18 (95%) 16 (94%) 
1.00 
Thrombolytic therapy (n [%]) 1 (5%) 1 (6%) 
CARDIAC REHABILITATION 
Cardiac rehabilitation (n [%]) 13 (65%) 11 (79%) 0.47 
SECONDARY EVENTS    
Elective PCI (n) 0 (0%) 6 (32%) <0.01 
Recurrent MI (n) 0 (0%) 2 (11%) 0.23 
MEDICATION 
Anticoagulant (n) 19 (95%) 19 (100%) 1.00 
 Anti-platelet (n) 18 (90%) 17 (89%) 1.00 
 Vitamin K antagonist (n) 1 (5%) 2 (11%) 0.61 
Antihypertensive agents (n) 14 (70%) 18 (95%) 0.09 
 ACE-inhibitor (n) 5 (25%) 14 (74%) <0.01 
 AT1-antagonist (n) 3 (15%) 3 (16%) 1.00 
 Beta-blocker (n) 8 (40%) 14 (74%) 0.05 
 Diuretic (n) 1 (5%) 4 (21%) 0.18 
 Calcium channel blockers (n) 1 (5%) 0 (0%) 1.00 
Lipid lowering agents (n) 16 (80%) 19 (100%) 0.11 
 Statins (n) 16 (80%) 18 (95%) 0.34 
*Based on a sub sample; hospital data not available 
MI: myocardial infarction; PCI: Percutaneous coronary intervention; CK: Creatine kinase; CREAT: Creatinine; 
ASAT: Aspartate transaminase; LDH: Lactate dehydrogenase; Non-STEMI: non-ST elevation acute coronary 
syndrome; ACE: angiotensin converting enzyme; AT: angiotensin. 
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Table 5. Vascular function and structure of the post-MI athletes (ATH+MI) and sedentary post-MI 
(SED+MI) controls. Data is presented as mean and standard deviation or median and interquartile 
range (IQR). P-value refers to an independent Student’s t test or Mann-Whitney U test. 
 
ATH+MI 
n=20 
SED+MI 
n=19 
p value 
VASCULAR FUNCTION 
FLOW MEDIATED DILATION 
 Baseline diameter (mm) 4.5 (4.1-4.8) 4.2 (3.7-4.6) 0.42 
 Peak dilation (%) 4.0±1.9 5.3±3.3 0.16 
 Shear Rate (AUC) 16646 (9987-23701) 16837 (12395-19196) 0.89 
CONDUIT ARTERY VASODILATORY CAPACITY 
 Baseline diameter (mm) 4.4±0.5 4.3±0.6 0.77 
 Peak dilation (%) 14.0±6.2 13.1±5.2 0.65 
 Shear Rate (AUC) 31593±9054 31394±9546 0.95 
GLYCERYL TRINITRATE DILATATION 
 Baseline diameter (mm) 4.3±0.6 4.4±0.6 0.82 
 Peak dilation (%) 16.0±6.2 13.8±4.8 0.23 
 FMD / GTN ratio 0.23 (0.18-0.41) 0.35 (0.19-0.49) 0.19 
VASCULAR STRUCTURE 
CAROTID ARTERY 
 IMT (mm) 0.79 (0.64-0.86) 0.77 (0.69-0.80) 0.64 
 Diameter (mm) 6.9 (6.5-7.2) 6.5 (6.2-7.1) 0.17 
 wall:lumen-ratio 0.11 (0.09-0.13) 0.12 (0.10-0.13) 0.26 
BRACHIAL ARTERY 
 IMT (mm) 0.48±0.1 0.46±0.11 0.47 
 Diameter (mm) 4.2 (3.6-5.1) 4.2 (3.8-4.6) 0.69 
 wall:lumen-ratio 0.11 (0.10-0.12) 0.11 (0.10-0.12) 0.71 
FEMORAL ARTERY 
 IMT (mm) 0.70 (0.65-0.82) 0.65 (0.56-0.71) 0.05 
 Diameter (mm) 7.4±0.8 6.9±0.9 0.10 
 wall:lumen-ratio 0.10 (0.09-0.11) 0.10 (0.08-0.11) 0.60 
AUC: area under the curve; IMT: Intima-media thickness 
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